Studio City International Stock Performance
| MSC Stock | USD 6.65 0.35 5.00% |
On a scale of 0 to 100, Studio City holds a performance score of 5. The entity has a beta of 0.18, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Studio City's returns are expected to increase less than the market. However, during the bear market, the loss of holding Studio City is expected to be smaller as well. Please check Studio City's skewness, and the relationship between the potential upside and rate of daily change , to make a quick decision on whether Studio City's existing price patterns will revert.
Risk-Adjusted Performance
5 of 100
Weak | Strong |
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Studio City International are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating basic indicators, Studio City exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 0.15 | Five Day Return 5.21 | Year To Date Return (2.49) | Ten Year Return (57.03) | All Time Return (57.03) |
1 | Meso Numismatics Announces Cellgenics Sponsorship of Three Prominent Regenerative Medicine Events in Peru This September | 09/09/2024 |
2 | Acquisition by Mcdonnell Patrick J of 5667 shares of Studio City subject to Rule 16b-3 | 09/13/2024 |
3 | Velocity MSC Shares its Chief Finance Officer, Betty Ong, Named Top Technology CFO of 2024 | 10/08/2024 |
4 | WaveBL Completes a New Groundbreaking Network Connectivity Proof of Value with Swift, the Participation of Five Global Banks, and Leading Ocean Carrier eBL Issu... | 10/15/2024 |
5 | Studio City International Shares Down 4.3 percent Heres What Happened | 10/16/2024 |
6 | Meso Numismatics Changes Name to Regenerative Medical Technology Group and Ticker Symbol to RMTG | 10/21/2024 |
7 | MSC INDUSTRIAL SUPPLY CO. REPORTS FISCAL 2024 FOURTH QUARTER AND FULL YEAR RESULTS | 10/24/2024 |
8 | Disposition of 3200 shares by Nastas Clifford D of Studio City subject to Rule 16b-3 | 10/25/2024 |
9 | MSC CRUISES ANUNCIA LA APERTURA DE VENTAS DE CRUCEROS POR ALASKA DESDE SEATTLE -- EL QUINTO PUERTO BASE DE LA LNEA EN ESTADOS UNIDOS | 10/28/2024 |
10 | Studio City International Non-GAAP EPADS of -0.03, revenue of 174.63M | 11/05/2024 |
11 | Regenerative Medical Technology Group Announces the Opening of New Clinic in Dubai on November 23 | 11/07/2024 |
12 | RMTG Achieves Operational Profitability Expands Sales by 52 percent for Q3 Year Over Year and Reaches Gross Profit Margin of 75 percent for Q3 | 11/19/2024 |
13 | Mesenchymal Stem Cells Market Set to Surpass USD 9.72 Billion by 2032 The Role of Biopharma Collaborations in Accelerating Growth | 11/21/2024 |
| Begin Period Cash Flow | 509.5 M | |
| Free Cash Flow | -175.7 M |
Studio |
Studio City Relative Risk vs. Return Landscape
If you would invest 578.00 in Studio City International on August 28, 2024 and sell it today you would earn a total of 87.00 from holding Studio City International or generate 15.05% return on investment over 90 days. Studio City International is generating 0.3416% of daily returns assuming volatility of 5.0113% on return distribution over 90 days investment horizon. In other words, 44% of stocks are less volatile than Studio, and above 94% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Studio City Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Studio City's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Studio City International, and traders can use it to determine the average amount a Studio City's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0682
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | MSC | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.01 actual daily | 44 56% of assets are more volatile |
Expected Return
| 0.34 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average Studio City is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Studio City by adding it to a well-diversified portfolio.
Studio City Fundamentals Growth
Studio Stock prices reflect investors' perceptions of the future prospects and financial health of Studio City, and Studio City fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Studio Stock performance.
| Return On Equity | -0.14 | ||||
| Return On Asset | 0.0099 | ||||
| Profit Margin | (0.14) % | ||||
| Operating Margin | 0.09 % | ||||
| Current Valuation | 3.35 B | ||||
| Shares Outstanding | 192.59 M | ||||
| Price To Earning | 83.45 X | ||||
| Price To Book | 1.91 X | ||||
| Price To Sales | 2.04 X | ||||
| Revenue | 445.54 M | ||||
| Gross Profit | (61.41 M) | ||||
| EBITDA | 152.8 M | ||||
| Net Income | (133.52 M) | ||||
| Cash And Equivalents | 509.52 M | ||||
| Cash Per Share | 3.86 X | ||||
| Total Debt | 2.35 B | ||||
| Debt To Equity | 2.34 % | ||||
| Current Ratio | 3.43 X | ||||
| Book Value Per Share | 3.19 X | ||||
| Cash Flow From Operations | (18.89 M) | ||||
| Earnings Per Share | (0.46) X | ||||
| Market Capitalization | 1.28 B | ||||
| Total Asset | 3.24 B | ||||
| Retained Earnings | (1.8 B) | ||||
| Working Capital | 159.27 M | ||||
| Current Asset | 494.62 M | ||||
| Current Liabilities | 273.49 M | ||||
About Studio City Performance
By analyzing Studio City's fundamental ratios, stakeholders can gain valuable insights into Studio City's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Studio City has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Studio City has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 6.18 | 5.87 | |
| Return On Tangible Assets | (0.04) | (0.04) | |
| Return On Assets | (0.04) | (0.04) | |
| Return On Equity | (0.18) | (0.19) |
Things to note about Studio City International performance evaluation
Checking the ongoing alerts about Studio City for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Studio City International help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Studio City had very high historical volatility over the last 90 days | |
| Studio City has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the last year's revenue of 445.54 M. Reported Net Loss for the year was (133.52 M) with loss before taxes, overhead, and interest of (61.41 M). | |
| Studio City International has about 509.52 M in cash with (18.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.86. | |
| Studio City has a poor financial position based on the latest SEC disclosures | |
| Latest headline from finance.yahoo.com: Mesenchymal Stem Cells Market Set to Surpass USD 9.72 Billion by 2032 The Role of Biopharma Collaborations in Accelerating Growth |
- Analyzing Studio City's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Studio City's stock is overvalued or undervalued compared to its peers.
- Examining Studio City's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Studio City's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Studio City's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Studio City's stock. These opinions can provide insight into Studio City's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Studio Stock analysis
When running Studio City's price analysis, check to measure Studio City's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Studio City is operating at the current time. Most of Studio City's value examination focuses on studying past and present price action to predict the probability of Studio City's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Studio City's price. Additionally, you may evaluate how the addition of Studio City to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |